TRICORT

TRICORT

Marketed by: Orion Oyj
Active ingredient: Triamcinoloni acetonidum
Other information: ointment used in mouth - 0.1 %

Available in: Finland
Language: English
Source: Fimea

TRICORT

TRICORT

Marketed by: Orion Oyj
Active ingredient: Triamcinoloni acetonidum
Other information: ointment used in mouth - 0.1 %

Available in: Finland
Language: English
Source: Fimea

TRIODENT

TRIODENT

Marketed by: Orion Oyj
Active ingredient: Dequalinii acetas,Dexamethasoni natrii phosphas
Other information: solution

Available in: Finland
Language: English
Source: Fimea

TUMS

TUMS

Marketed by: NORCLIFF
Active ingredient: Calcii carbonas
Other information: tablet - 500 mg

Available in: Finland
Language: English
Source: Fimea

TALAKT

TALAKT

Marketed by: Glaxo Wellcome Production
Active ingredient: Natrii polyhydroxyaluminii monocarbonas hexitolcomp
Other information: tablet - 360 mg

Available in: Finland
Language: English
Source: Fimea

TALCID

TALCID

Marketed by: Bayer AG
Active ingredient: Hydrotalcitum
Other information: chewable tablet - 500 mg

Available in: Finland
Language: English
Source: Fimea

TALCID

TALCID

Marketed by: Bayer AG
Active ingredient: Hydrotalcitum
Other information: oral liquid - 100 mg/ml

Available in: Finland
Language: English
Source: Fimea

TALIDAT

TALIDAT

Marketed by: Merck Oy Lääkeosasto
Active ingredient: Hydrotalcitum
Other information: chewable tablet - 500 mg

Available in: Finland
Language: English
Source: Fimea

TALCID

TALCID

Marketed by: Schering Oy
Active ingredient: Hydrotalcitum
Other information: chewable tablet - 500 mg

Available in: Finland
Language: English
Source: Fimea

TALCID

TALCID

Marketed by: Schering Oy
Active ingredient: Hydrotalcitum
Other information: oral liquid - 100 mg/ml

Available in: Finland
Language: English
Source: Fimea

TAGAMET

TAGAMET

Marketed by: SmithKline Beecham Ltd
Active ingredient: Cimetidinum
Other information: effervescent tablet - 200 mg

Available in: Finland
Language: English
Source: Fimea

TAGAMET

TAGAMET

Marketed by: SmithKline Beecham Ltd
Active ingredient: Cimetidinum
Other information: effervescent tablet - 400 mg

Available in: Finland
Language: English
Source: Fimea

TAGAMET

TAGAMET

Marketed by: Orion Oyj
Active ingredient: Cimetidinum
Other information: injection - 100 mg/ml

Available in: Finland
Language: English
Source: Fimea

TAGAMET

TAGAMET

Marketed by: SmithKline Beecham Ltd
Active ingredient: Cimetidinum
Other information: film-coated tablet - 200 mg

Available in: Finland
Language: English
Source: Fimea

TAGAMET

TAGAMET

Marketed by: Orion Oyj
Active ingredient: Cimetidinum
Other information: oral liquid - 40 mg/ml

Available in: Finland
Language: English
Source: Fimea

TAGAMET

TAGAMET

Marketed by: SmithKline Beecham Ltd
Active ingredient: Cimetidinum
Other information: film-coated tablet - 400 mg

Available in: Finland
Language: English
Source: Fimea

TAGAMET

TAGAMET

Marketed by: SmithKline Beecham Ltd
Active ingredient: Cimetidinum
Other information: film-coated tablet - 800 mg

Available in: Finland
Language: English
Source: Fimea

TOPALKAN

TOPALKAN

Marketed by: Pierre Fabre Medicament
Active ingredient: Acidum alginicum,Aluminii hydroxidum colloidale,Magnesii subcarbonas levis
Other information: chewable tablet

Available in: Finland
Language: English
Source: Fimea

TARODYL

TARODYL

Marketed by: H.Lundbeck A/S
Active ingredient: Glycopyrronii bromidum
Other information: tablet - 1 mg

Available in: Finland
Language: English
Source: Fimea

TIFISETRON

TIFISETRON

Marketed by: Alfred E.Tiefenbacher GmbH & Co. KG
Active ingredient: Ondansetroni hydrochloridum dihydricum
Other information: film-coated tablet - 4 mg

Available in: Finland
Language: English
Source: Fimea

TIFISETRON

TIFISETRON

Marketed by: Alfred E.Tiefenbacher GmbH & Co. KG
Active ingredient: Ondansetroni hydrochloridum dihydricum
Other information: film-coated tablet - 8 mg

Available in: Finland
Language: English
Source: Fimea

TIFISETRON

TIFISETRON

Marketed by: Alfred E.Tiefenbacher GmbH & Co. KG
Active ingredient: Ondansetroni hydrochloridum dihydricum
Other information: solution for injection - 2 mg/ml

Available in: Finland
Language: English
Source: Fimea

TOILAX YHDISTELMÄPAKKAUS

TOILAX YHDISTELMÄPAKKAUS

Marketed by: Orion Oyj
Active ingredient: Bisacodylum
Other information: gastro-resistant tablet and rectal suspension

Available in: Finland
Language: English
Source: Fimea

TOILAX

TOILAX

Marketed by: Orion Oyj
Active ingredient: Bisacodylum
Other information: gastro-resistant tablet - 5 mg

Available in: Finland
Language: English
Source: Fimea

TRI BRANDRETH'IN PILLERIT

TRI BRANDRETH'IN PILLERIT

Marketed by: ROHTO
Active ingredient: Aloe,Guaiacum,Extractum rhamni pursianae siccatum,Fructus capsici
Other information: pill

Available in: Finland
Language: English
Source: Fimea

TRANSIPEG

TRANSIPEG

Marketed by: Bayer Oy
Active ingredient: Macrogolum 3350
Other information: powder for oral solution - 2.95 g

Available in: Finland
Language: English
Source: Fimea

TRANSIPEG

TRANSIPEG

Marketed by: Bayer Oy
Active ingredient: Macrogolum 3350
Other information: powder for oral solution in single-dose container - 5.9 g

Available in: Finland
Language: English
Source: Fimea

TOILAX

TOILAX

Marketed by: Orion Oyj
Active ingredient: Bisacodylum
Other information: rectal suspension - 2 mg/ml

Available in: Finland
Language: English
Source: Fimea

TOILAX

TOILAX

Marketed by: Orion Pharma A/S
Active ingredient: Bisacodylum
Other information: solution - 2 mg/ml

Available in: Finland
Language: English
Source: Fimea

TANNOPON

TANNOPON

Marketed by: NEOFARMA
Active ingredient: Extractum opii (20%),Albumini tannas,Extractum belladonnae (1,4%),Bismuthi subsalicylas
Other information: tablet

Available in: Finland
Language: English
Source: Fimea